FDA advisers back gene therapy for rare form of blindness – Nature.com
Nature.com |
FDA advisers back gene therapy for rare form of blindness
Nature.com Advisers to the US Food and Drug Administration (FDA) have paved the way for the agency's first approval of a gene therapy to treat a disease caused by a genetic mutation. On 12 October, a panel of external experts unanimously voted that the benefits … FDA advisers urge approval for first gene therapy for inherited disease FDA Panel Advises Approval of Gene Therapy for Blinding Disease FDA Vote Sets Stage for Gene Therapy's Future |
